Change in impulsivity is prospectively associated with treatment outcomes for binge-eating disorder
- PMID: 34812713
- PMCID: PMC9124732
- DOI: 10.1017/S003329172100475X
Change in impulsivity is prospectively associated with treatment outcomes for binge-eating disorder
Abstract
Background: Impulsivity may be a process underlying binge-eating disorder (BED) psychopathology and its treatment. This study examined change in impulsivity during cognitive-behavioral therapy (CBT) and/or pharmacological treatment for BED and associations with treatment outcomes.
Methods: In total, 108 patients with BED (NFEMALE = 84) in a randomized placebo-controlled clinical trial evaluating the efficacy of CBT and/or fluoxetine were assessed before treatment, monthly throughout treatment, at post-treatment (16 weeks), and at 12-month follow-up after completing treatment. Patients completed established measures of impulsivity, eating-disorder psychopathology, and depression, and were measured for height and weight [to calculate body mass index (BMI)] during repeated assessments by trained/monitored doctoral research-clinicians. Mixed-effects models using all available data examined changes in impulsivity and the association of rapid and overall changes in impulsivity on treatment outcomes. Exploratory analyses examined whether baseline impulsivity predicted/moderated outcomes.
Results: Impulsivity declined significantly throughout treatment and follow-up across treatment groups. Rapid change in impulsivity and overall change in impulsivity during treatment were significantly associated with reductions in eating-disorder psychopathology, depression scores, and BMI during treatment and at post-treatment. Overall change in impulsivity during treatment was associated with subsequent reductions in depression scores at 12-month follow-up. Baseline impulsivity did not moderate/predict eating-disorder outcomes or BMI but did predict change in depression scores.
Conclusions: Rapid and overall reductions in impulsivity during treatment were associated with improvements in specific eating-disorder psychopathology and associated general outcomes. These effects were found for both CBT and pharmacological treatment for BED. Change in impulsivity may be an important process prospectively related to treatment outcome.
Keywords: Binge-eating disorder; cognitive-behavioral therapy; eating disorders; fluoxetine; impulsivity; obesity; treatment.
Conflict of interest statement
Conflicts of Interest
The authors (Boswell, Gueorguieva, and Grilo) report no conflicts of interest. Drs. Grilo and Gueorguieva report several broader interests which did not influence this research or paper. During the past 12 months, Dr. Grilo’s broader interests include Honoraria for lectures and CME activities and Royalties from Guilford Press and Taylor & Francis Publishers for academic books. Dr. Gueorguieva discloses consulting for Cohen Veterans Biosciences and a provisional patent submission by Yale University: Chekroud, AM., Gueorguieva, R., & Krystal, JH. “Treatment Selection for Major Depressive Disorder” [filing date 3rd June 2016, USPTO docket number Y0087.70116US00], and Royalties from Taylor & Francis for an academic book.
Figures



References
-
- APA. (1994). Diagnostic and statistical manual of mental disorders (4th ed). Washington, D.C. : American Psychiatric Association.
-
- APA. (2013). Diagnostic and statistical manual of mental disorders (5th ed). Arlington, VA: American Psychiatric Association.
-
- Balodis IM, Grilo CM, Kober H, Worhunsky PD, White MA, Stevens MC, … Potenza MN (2014). A pilot study linking reduced fronto-Striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder. International Journal of Eating Disorders, 47(4), 376–384. doi: 10.1002/eat.22204 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources